Koyfin Home > Directory > Health Care > Aimmune Therap > Preferred Equity

Aimmune Therap Preferred Equity Chart (AIMT)

Aimmune Therap annual/quarterly Preferred Equity from 2014 to 2015.
  • Aimmune Therap Preferred Equity for the quarter ending June 06, 2015 was $84m
  • Aimmune Therap Preferred Equity for the last 12 months ending June 06, 2015 was $84m
  • Aimmune Therap Annual Preferred Equity for 2014 was $17m a 0.00% decrease of 0m from 2013
  • Aimmune Therap Annual Preferred Equity for 2013 was $17m
Other Balance Sheet Metrics:
  • Aimmune Therap Total Assets for the quarter ending September 09, 2018 was $287m a 28.01% increase of 81m year over year
  • Aimmune Therap Other Liabilities for the quarter ending December 12, 2018 was $3m a 9.82% increase of 0m year over year
  • Aimmune Therap Total Equity for the quarter ending September 09, 2018 was $247m a 28.06% increase of 69m year over year
View Chart On Koyfin

Quarterly AIMT Preferred Equity Data

06/2015$84m
12/2014$17m
03/2014$17m

Annual AIMT Preferred Equity Data

2014$17m
2013$17m